Current studies have revealed the connections between SELENOF polymorphisms and various risks of cancers, including colorectal cancer, lung cancer, breast cancer, and prostate cancer [11,12], yet the results from different populations can be conflicting and inconclusive. Here, SELENOF is linked to cancer.